Ligand-independent coregulator recruitment by the triply activatable or1/retinoid x receptor-α nuclear receptor heterodimer

Molecular Endocrinology

Volumn 13, Issue 7, 1999, Pages 1105-1118

  Wiebel, Franziska F ^a,b   Steffensen, Knut Rune ^a,c   Treuter, Eckardt ^a   Feltkamp, Dorothee ^a   Gustafsson, Jan Åke ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; RETINOID X RECEPTOR;

ARTICLE; CONTROLLED STUDY; DIMERIZATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

EID: 0033326582     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.7.0292     Document Type: Article

References (68)

1. Transcription factors 3: Nuclear receptors
2. The nuclear receptor superfamily: The second decade
3. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
4. Nuclear receptors spring into action
5. A canonical structure for the ligand-binding domain of nuclear receptors
6. The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing
7. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor
8. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: Presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity
9. The RXR heterodimers and orphan receptors
10. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation
11. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: Binding and activation correlate with antidiabetic actions in db/db mice
12. Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping
13. Crystal structure of the RAR-γ, ligand-binding domain bound to all-trans retinoic acid
14. A structural role for hormone in the thyroid hormone receptor
15. Unique response pathways are established by allosteric interactions among nuclear hormone receptors
16. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding
17. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers
18. Functional ecdysone receptor is the product of EcR and Ultraspiracle genes
19. NER, a new member of the gene family encoding the human steroid hormone nuclear receptor
20. Ubiquitous receptor: A receptor that modulates gene activation by retinoic acid and thyroid hormone receptors
21. OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor
22. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily
23. LXR, a nuclear receptor that defines a distinct retinoid response pathway
24. An oxysterol signalling pathway mediated by the nuclear receptor LXRα
25. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway
26. The LXRs - A new class of oxysterol receptors
27. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR-α
28. Heterodimeric interaction between retinoid X receptor α and orphan nuclear receptor OR1 reveals dimerization-induced activation as a novel mechanism of nuclear receptor activation
29. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements
30. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR
31. Nuclear receptor coactivators
32. Nuclear receptor coactivators and corepressors
33. Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression
34. Activation of specific RXR heterodimers by an antagonist of RXR homodimers
35. Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF
36. The CBP co-activator is a histone acetyltransferase
37. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
38. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
39. Nuclear receptor repression mediated by a complex containing SMRT, msin3a, and histone deacetylase
40. The transcriptional coactivators p300 and CBP are histone acetyltransferases
41. Steroid receptor coactivator-1 is a histone acetyltransferase
42. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
43. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
44. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription
45. A regulatory role for RIP140 in nuclear receptor activation
46. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
47. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
48. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor
49. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
50. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
51. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
52. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300
53. RIP140 interacts with multiple nuclear receptors by means of two distinct sites
54. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR
55. The orphan nuclear receptor LXRα is positively and negatively regulated by distinct products of mevalonate metabolism
56. A natural transactivation mutation in the thyroid hormone beta receptor: Impaired interaction with putative transcriptional mediators
57. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid x receptor heterodimers with ligands, coactivators, and corepressors
58. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
59. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
60. RIP140 enhances nuclear receptor-dependent transcription in vivo in yeast
61. Evidence For ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction
62. Cloning and characterization of mouse RIP140, a corepressor for nuclear orphan receptor TR2
63. Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1 nuclear receptor transcriptional synergy
64. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
65. A transcriptional co-repressor that interacts with nuclear hormone receptors
66. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid
67. The phantom ligand effect: Allosteric control of transcription by the retinoid X receptor
68. 1993 Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor